BSE:532834

Stock Analysis Report

Camlin Fine Sciences

Executive Summary

Camlin Fine Sciences Limited engages in the research, development, manufacture, commercialization, and marketing of specialty chemical and blend products in India, Mexico, Central and North America, China, Europe, Singapore, Argentina, Brazil, and internationally.


Snowflake Analysis

Reasonable growth potential with adequate balance sheet.


Similar Companies

Share Price & News

How has Camlin Fine Sciences's share price performed over time and what events caused price changes?


Latest Share Price and Events

Stable Share Price: 532834's share price has been volatile over the past 3 months.


Market Performance


7 Day Return

11.4%

532834

-2.4%

IN Chemicals

-3.9%

IN Market


1 Year Return

-15.7%

532834

-17.4%

IN Chemicals

-32.2%

IN Market

Return vs Industry: 532834 underperformed the Indian Chemicals industry which returned -14.6% over the past year.

Return vs Market: 532834 exceeded the Indian Market which returned -30.7% over the past year.


Shareholder returns

532834IndustryMarket
7 Day11.4%-2.4%-3.9%
30 Day-39.8%-23.2%-26.8%
90 Day-50.4%-21.2%-31.7%
1 Year-15.7%-15.7%-13.9%-17.4%-30.8%-32.2%
3 Year-57.2%-57.2%9.6%2.8%-19.5%-23.8%
5 Year-57.0%-57.4%58.3%44.7%-10.0%-14.9%

Price Volatility Vs. Market

How volatile is Camlin Fine Sciences's share price compared to the market and industry in the last 5 years?


Simply Wall St News

No news available

Valuation

Is Camlin Fine Sciences undervalued compared to its fair value and its price relative to the market?

14.37x

Price to Earnings (PE) ratio


Share Price vs. Fair Value

Below Fair Value: 532834 (₹41.5) is trading above our estimate of fair value (₹6.62)

Significantly Below Fair Value: 532834 is trading above our estimate of fair value.


Price To Earnings Ratio

PE vs Industry: 532834 is poor value based on its PE Ratio (14.4x) compared to the Chemicals industry average (7.7x).

PE vs Market: 532834 is poor value based on its PE Ratio (14.4x) compared to the Indian market (9.4x).


Price to Earnings Growth Ratio

PEG Ratio: 532834 is good value based on its PEG Ratio (0.3x)


Price to Book Ratio

PB vs Industry: 532834 is overvalued based on its PB Ratio (1.3x) compared to the IN Chemicals industry average (0.8x).


Next Steps

Future Growth

How is Camlin Fine Sciences forecast to perform in the next 1 to 3 years based on estimates from 2 analysts?

45.9%

Forecasted annual earnings growth


Earnings and Revenue Growth Forecasts


Analyst Future Growth Forecasts

Earnings vs Savings Rate: 532834's forecast earnings growth (45.9% per year) is above the savings rate (6.5%).

Earnings vs Market: 532834's earnings (45.9% per year) are forecast to grow faster than the Indian market (19.2% per year).

High Growth Earnings: earnings are expected to grow significantly over the next 3 years.

Revenue vs Market: 532834's revenue (15.8% per year) is forecast to grow faster than the Indian market (8.8% per year).

High Growth Revenue: 532834's revenue (15.8% per year) is forecast to grow slower than 20% per year.


Earnings per Share Growth Forecasts


Future Return on Equity

Future ROE: Insufficient data to determine if 532834's Return on Equity is forecast to be high in 3 years time


Next Steps

Past Performance

How has Camlin Fine Sciences performed over the past 5 years?

-34.8%

Historical annual earnings growth


Earnings and Revenue History

Quality Earnings: 532834 has high quality earnings.

Growing Profit Margin: 532834 became profitable in the past.


Past Earnings Growth Analysis

Earnings Trend: 532834's earnings have declined by -34.8% per year over the past 5 years.

Accelerating Growth: 532834 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 532834 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Chemicals industry (10%).


Return on Equity

High ROE: 532834's Return on Equity (7.5%) is considered low.


Next Steps

Financial Health

How is Camlin Fine Sciences's financial position?


Financial Position Analysis

Short Term Liabilities: 532834's short term assets (₹6.1B) exceed its short term liabilities (₹4.7B).

Long Term Liabilities: 532834's short term assets (₹6.1B) exceed its long term liabilities (₹2.0B).


Debt to Equity History and Analysis

Debt Level: 532834's debt to equity ratio (102.4%) is considered high.

Reducing Debt: 532834's debt to equity ratio has reduced from 122.9% to 102.4% over the past 5 years.

Debt Coverage: 532834's debt is not well covered by operating cash flow (9.1%).

Interest Coverage: 532834's interest payments on its debt are well covered by EBIT (3.8x coverage).


Balance Sheet

Inventory Level: 532834 has a high level of physical assets or inventory.

Debt Coverage by Assets: 532834's debt is covered by short term assets (assets are 1.3x debt).


Next Steps

Dividend

What is Camlin Fine Sciences's current dividend yield, its reliability and sustainability?


Dividend Yield vs Market

Notable Dividend: Unable to evaluate 532834's dividend yield against the bottom 25% of dividend payers, as the company has not reported any payouts.

High Dividend: Unable to evaluate 532834's dividend yield against the top 25% of dividend payers, as the company has not reported any payouts.


Stability and Growth of Payments

Stable Dividend: Insufficient data to determine if 532834's dividends per share have been stable in the past.

Growing Dividend: Insufficient data to determine if 532834's dividend payments have been increasing.


Current Payout to Shareholders

Dividend Coverage: 532834 is not paying a notable dividend for the Indian market.


Future Payout to Shareholders

Future Dividend Coverage: No need to calculate the sustainability of 532834's dividend in 3 years as they are not forecast to pay a notable one for the Indian market.


Next Steps

Management

How experienced are the management team and are they aligned to shareholders interests?

3.2yrs

Average management tenure


CEO

Ashish Dandekar (55yo)

9.58s

Tenure

₹18,481,000

Compensation

Mr. Ashish Subhash Dandekar has been the Managing Director of Camlin Fine Chemicals Ltd. since September 1, 2010 and serves as its Director. Mr. Dandekar has wide experience of 30 years in the field of Pha ...


CEO Compensation Analysis

Compensation vs Market: Ashish's total compensation ($USD242.46K) is above average for companies of similar size in the Indian market ($USD47.81K).

Compensation vs Earnings: Ashish's compensation has been consistent with company performance over the past year.


Leadership Team

NamePositionTenureCompensationOwnership
Ashish Dandekar
MD & Director9.58yrs₹18.48m11.6% 583.5m
Santosh Parab
Chief Financial Officer3.17yrsno data0.00082% 41.3k
Arjun Dukane
Global Senior Vice President of Manufacturing1.83yrs₹4.13m0.091% 4.6m
Mondor Godbole
Compliance Officer0.17yrno datano data
Subhash Dandekar
Management Consultant & Senior Corporate Advisorno datano data1.69% 84.9m
Rajani Dandekar
Management Consultantno datano data0.43% 21.8m

3.2yrs

Average Tenure

53.5yo

Average Age

Experienced Management: 532834's management team is considered experienced (3.2 years average tenure).


Board Members

NamePositionTenureCompensationOwnership
Ashish Dandekar
MD & Director9.58yrs₹18.48m11.6% 583.5m
Arjun Dukane
Global Senior Vice President of Manufacturing1.83yrs₹4.13m0.091% 4.6m
Sharad Kulkarni
Independent Director13.42yrs₹1.03m0.13% 6.7m
Abeezar Faizullabhoy
Independent Director13.42yrs₹1.05m0.15% 7.7m
Pramod Sapre
Independent Director13.83yrs₹1.08m0.087% 4.4m
Dilip Dandekar
Non Executive Chairmanno data₹3.77m1.31% 66.0m
Bhargav Patel
Independent Director11.25yrs₹1.00m0.12% 6.2m
Nirmal Momaya
Non Executive Director5.67yrs₹500.00k2.97% 149.5m
Atul Pradhan
Independent Director5.67yrs₹550.00k0.018% 892.2k
Nicola Paglietti
Independent Director5.67yrs₹200.00kno data

8.5yrs

Average Tenure

55yo

Average Age

Experienced Board: 532834's board of directors are considered experienced (8.5 years average tenure).


Ownership

Who are the major shareholders and have insiders been buying or selling?


Insider Trading Volume

Insider Buying: Insufficient data to determine if insiders have bought more shares than they have sold in the past 3 months.


Recent Insider Transactions

Ownership Breakdown

Dilution of Shares: Shareholders have not been meaningfully diluted in the past year.


Top Shareholders

Company Information

Camlin Fine Sciences Limited's company bio, employee growth, exchange listings and data sources


Key Information

  • Name: Camlin Fine Sciences Limited
  • Ticker: 532834
  • Exchange: BSE
  • Founded: 1931
  • Industry: Specialty Chemicals
  • Sector: Materials
  • Market Cap: ₹5.032b
  • Shares outstanding: 121.25m
  • Website: https://www.camlinfs.com

Number of Employees


Location

  • Camlin Fine Sciences Limited
  • Plot No. F/11 & F/12, WICEL
  • Opposite SEEPZ Main Gate
  • Mumbai
  • Maharashtra
  • 400093
  • India

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
532834BSE (Mumbai Stock Exchange)YesEquity SharesININRMar 2007
CAMLINFINENSEI (National Stock Exchange of India)YesEquity SharesININRMar 2007

Biography

Camlin Fine Sciences Limited engages in the research, development, manufacture, commercialization, and marketing of specialty chemical and blend products in India, Mexico, Central and North America, China, Europe, Singapore, Argentina, Brazil, and internationally. It offers shelf-life extension solutions, such as a range of antioxidant solutions that are used to enhance the shelf life of oils and fats under the Xtendra and NaSure brands. The company also provides aroma ingredients, including vanillin and ethyl vanillin under the Vanesse and Evanil brands. In addition, it offers performance chemicals, such as guaiacol, veratrole, 4- tert-Butylcatechol, 4- methoxyphenol, TBHQ tech, hydroquinone, guethol, and catechol, as well as 1, 2-diethoxybenzene and 2- chloro-1,4 dimethoxybenzene. Further, the company manufactures and markets various animal nutrition products, antioxidants, adsorbents, acidifying agents, bactericides, binders, and mold inhibitors. It also exports its products. The company’s products are used in food and beverage, pet food and animal nutrition, rendering, aqua culture, bio-fuels, flavor and fragrance, pharmaceutical, petrochemical, agrochemical, dyes and pigment, textile and tanning, biodiesel, and cosmetics industries. The company was formerly known as Camlin Fine Chemicals Limited and changed its name to Camlin Fine Sciences Limited in August 2011. Camlin Fine Sciences Limited was founded in 1931 and is headquartered in Mumbai, India. 


Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2020/04/03 14:03
End of Day Share Price2020/04/03 00:00
Earnings2019/12/31
Annual Earnings2019/03/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.